TTC5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.180200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.650200E-01
Normal-vs-Stage2
7.570400E-01
Normal-vs-Stage3
2.604100E-02
Normal-vs-Stage4
8.017400E-01
Stage1-vs-Stage2
2.185600E-01
Stage1-vs-Stage3
2.135700E-02
Stage1-vs-Stage4
9.170600E-01
Stage2-vs-Stage3
8.593500E-02
Stage2-vs-Stage4
4.037000E-01
Stage3-vs-Stage4
1.610750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.297200E-01
Normal-vs-AfricanAmerican
8.708000E-01
Normal-vs-Asian
2.899200E-01
Caucasian-vs-AfricanAmerican
7.224800E-01
Caucasian-vs-Asian
1.387010E-01
AfricanAmerican-vs-Asian
1.667360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.467400E-01
Normal-vs-Female
9.837400E-01
Male-vs-Female
5.686000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.034200E-01
Normal-vs-Age(41-60Yrs)
7.785400E-01
Normal-vs-Age(61-80Yrs)
7.773000E-01
Normal-vs-Age(81-100Yrs)
5.194000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.863400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.069800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.800100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.220200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.009700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.600000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.863800E-01
Normal-vs-Daily Drinker
5.779000E-01
Normal-vs-Weekly Drinker
2.438600E-01
Normal-vs-Occasional Drinker
6.386600E-01
Normal-vs-Social Drinker
9.695400E-01
Non Drinker-vs-Daily Drinker
9.459600E-01
Non Drinker-vs-Weekly Drinker
3.803400E-01
Non Drinker-vs-Occasional Drinker
8.112000E-02
Non Drinker-vs-Social Drinker
3.703600E-01
Daily Drinker-vs-Weekly Drinker
4.227800E-01
Daily Drinker-vs-Occasional Drinker
9.658100E-02
Daily Drinker-vs-Social Drinker
3.763600E-01
Weekly Drinker-vs-Occasional Drinker
3.652300E-02
Weekly Drinker-vs-Social Drinker
1.745650E-01
Occasional Drinker-vs-Social Drinker
4.031600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.883400E-01
Normal-vs-Grade 2
1.964420E-02
Normal-vs-Grade 3
1.952090E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.397430E-01
Grade 1-vs-Grade 3
3.653200E-01
Grade 1-vs-Grade 4
1.883400E-01
Grade 2-vs-Grade 3
1.682190E-01
Grade 2-vs-Grade 4
1.964420E-02
Grade 3-vs-Grade 4
1.952090E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.798400E-01
Normal-vs-NonDiabetic
9.116200E-01
Diabetic-vs-NonDiabetic
2.517000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.032100E-02
Normal-vs-NoPancreatitis
9.210200E-01
Pancreatitis-vs-NoPancreatitis
8.182800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.598600E-01
Normal-vs-N1
8.072600E-01
N0-vs-N1
4.690600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.724800E-01
Normal-vs-TP53-NonMutant
9.169000E-01
TP53-Mutant-vs-TP53-NonMutant
6.137000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
